Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types
Sadiq Umar(University of Illinois Chicago), Shiva Shahrara(University of Illinois Chicago), Chandana Tetali(University of Illinois Chicago), Karol Palasiewicz(University of Illinois Chicago), Christian Ascoli(University of Illinois Chicago), Rani Rahat, Shiva Arami(University of Illinois Chicago), Luke O'neill(Trinity College Dublin), Mónica Gumá(University of California San Diego), Michael V. Volin(Midwestern University), Bianca Romay(University of Illinois Chicago), Nadera Sweiss(University of Illinois Chicago), Ryan K. Zomorrodi(University of Illinois Chicago)
Cited by 63
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
|Cell Research|2015|1.8k
Targeting Toll-like receptors: emerging therapeutics?
|Nature Reviews Drug Discovery|2010|883
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
|Cell Metabolism|2020|571